Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Tachykinin antagonist with potential as antiasthmatic

Aug. 19, 1997

Cortecs announces phase II results for Pseudostat in chronic bronchitis

Aug. 14, 1997

FDA approves IND for cystic fibrosis drug

Aug. 13, 1997

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

First European clinical trials of pranlukast reported

Aug. 11, 1997

Orally active PDE IV inhibitors from Merck Frosst

Aug. 11, 1997

Allegra now available in Canada

Aug. 6, 1997

Anti-IL-4 MAb effective in murine model of asthma

Aug. 5, 1997

Leukotriene synthesis inhibitors in development at Bayer

Aug. 5, 1997

Nonpeptide NK3 antagonists from SmithKline Beecham

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...